vs
Side-by-side financial comparison of Ascent Solar Technologies, Inc. (ASTI) and FRACTYL HEALTH, INC. (GUTS). Click either name above to swap in a different company.
Ascent Solar Technologies, Inc. is the larger business by last-quarter revenue ($15.6K vs $14.0K, roughly 1.1× FRACTYL HEALTH, INC.). Ascent Solar Technologies, Inc. produced more free cash flow last quarter ($-6.9M vs $-18.3M).
Ascent Solar Technologies, Inc. is a publicly traded photovoltaic (PV) company located in Thornton, Colorado. Its primary product is a flexible CIGS solar cell on a plastic substrate.
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1 (GLP-1).
ASTI vs GUTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $15.6K | $14.0K |
| Net Profit | — | $-23.2M |
| Gross Margin | — | 50.0% |
| Operating Margin | — | -169957.1% |
| Net Margin | — | -165521.4% |
| Revenue YoY | — | — |
| Net Profit YoY | -42.3% | — |
| EPS (diluted) | — | $-0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.6K | — | ||
| Q3 25 | $28.5K | — | ||
| Q2 25 | $17.0K | — | ||
| Q1 25 | $15.6K | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $8.6K | $14.0K | ||
| Q2 24 | $27.7K | $43.0K | ||
| Q1 24 | $5.6K | $33.0K |
| Q4 25 | — | — | ||
| Q3 25 | $-2.0M | — | ||
| Q2 25 | $-2.1M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-1.5M | — | ||
| Q3 24 | $-1.7M | $-23.2M | ||
| Q2 24 | $-3.4M | $-17.2M | ||
| Q1 24 | $-2.5M | $-3.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 44.2% | ||
| Q1 24 | — | 42.4% |
| Q4 25 | — | — | ||
| Q3 25 | -6892.3% | — | ||
| Q2 25 | -12316.8% | — | ||
| Q1 25 | -11177.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -26443.2% | -169957.1% | ||
| Q2 24 | -8490.7% | -53453.5% | ||
| Q1 24 | -44206.0% | -65278.8% |
| Q4 25 | — | — | ||
| Q3 25 | -7081.3% | — | ||
| Q2 25 | -12177.3% | — | ||
| Q1 25 | -10716.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -19776.2% | -165521.4% | ||
| Q2 24 | -12420.5% | -40067.4% | ||
| Q1 24 | -45316.8% | -10066.7% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.62 | — | ||
| Q2 25 | $-1.17 | — | ||
| Q1 25 | $-1.13 | — | ||
| Q4 24 | $50.75 | — | ||
| Q3 24 | $-1.37 | $-0.48 | ||
| Q2 24 | $-6.76 | $-0.36 | ||
| Q1 24 | $-53.00 | $-0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.8M | $84.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.3M | $50.3M |
| Total Assets | $6.3M | $126.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.8M | — | ||
| Q3 25 | $2.1M | — | ||
| Q2 25 | $3.0M | — | ||
| Q1 25 | $2.3M | — | ||
| Q4 24 | $3.2M | — | ||
| Q3 24 | $3.7M | $84.7M | ||
| Q2 24 | $5.8M | $102.4M | ||
| Q1 24 | $187.5K | $121.4M |
| Q4 25 | $3.3M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $3.4M | — | ||
| Q1 25 | $2.6M | — | ||
| Q4 24 | $3.4M | — | ||
| Q3 24 | $-3.3M | $50.3M | ||
| Q2 24 | $4.2M | $70.8M | ||
| Q1 24 | $-2.6M | $84.2M |
| Q4 25 | $6.3M | — | ||
| Q3 25 | $5.8M | — | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $6.2M | — | ||
| Q4 24 | $7.1M | — | ||
| Q3 24 | $7.9M | $126.9M | ||
| Q2 24 | $10.2M | $146.4M | ||
| Q1 24 | $5.0M | $163.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.9M | $-18.0M |
| Free Cash FlowOCF − Capex | $-6.9M | $-18.3M |
| FCF MarginFCF / Revenue | -44350.5% | -130371.4% |
| Capex IntensityCapex / Revenue | 204.7% | 1521.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.9M | — | ||
| Q3 25 | $-1.7M | — | ||
| Q2 25 | $-1.8M | — | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | $-1.5M | — | ||
| Q3 24 | $-2.1M | $-18.0M | ||
| Q2 24 | $-3.6M | $-18.7M | ||
| Q1 24 | $-1.2M | $-11.7M |
| Q4 25 | $-6.9M | — | ||
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $-1.8M | — | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-18.3M | ||
| Q2 24 | — | $-19.0M | ||
| Q1 24 | — | $-12.8M |
| Q4 25 | -44350.5% | — | ||
| Q3 25 | -6182.5% | — | ||
| Q2 25 | -10692.4% | — | ||
| Q1 25 | -9923.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -130371.4% | ||
| Q2 24 | — | -44179.1% | ||
| Q1 24 | — | -38697.0% |
| Q4 25 | 204.7% | — | ||
| Q3 25 | 103.3% | — | ||
| Q2 25 | 12.0% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1521.4% | ||
| Q2 24 | — | 604.7% | ||
| Q1 24 | — | 3209.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
